These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9365389

  • 1. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption.
    Clemens JD, Herrick MV, Singer FR, Eyre DR.
    Clin Chem; 1997 Nov; 43(11):2058-63. PubMed ID: 9365389
    [Abstract] [Full Text] [Related]

  • 2. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I, Taguchi Y, Chaki O, Nakayama M, Minaguchi H.
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [Abstract] [Full Text] [Related]

  • 3. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
    Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S.
    Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
    [Abstract] [Full Text] [Related]

  • 4. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE, Frölich M.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An oral cathepsin K inhibitor ONO-5334 inhibits N-terminal and C-terminal collagen crosslinks in serum and urine at similar plasma concentrations in postmenopausal women.
    Tanaka M, Hashimoto Y, Hasegawa C.
    Bone; 2015 Dec; 81():178-185. PubMed ID: 26188109
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
    Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C.
    Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M, Alfano FS, Gatti C, Fantuzzi M, Girasole G, Campanini C, Basini G, Passeri M.
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [Abstract] [Full Text] [Related]

  • 12. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
    Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL.
    Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
    Sone T, Miyake M, Takeda N, Fukunaga M.
    Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
    [Abstract] [Full Text] [Related]

  • 15. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y, Jia W, Zhang H, Dong J, Clemens JD, Tian X.
    Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L.
    J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.